Cysteine protease activity in the wall of abdominal aortic aneurysms

Journal of Vascular Surgery

Volumn 46, Issue 6, 2007, Pages 1260-1266

  Abisi, Said ^a   Burnand, Kevin G ^a   Waltham, Matthew ^a   Humphries, Julia ^a   Taylor, Peter R ^b   Smith, Alberto ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; COLLAGEN; CYSTATIN C; CYSTEINE PROTEINASE; ELASTIN; GELATINASE B;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; AORTA OCCLUSION; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

AGED; AORTA; AORTIC ANEURYSM, ABDOMINAL; AORTIC DISEASES; ARTERIAL OCCLUSIVE DISEASES; CATHEPSINS; CYSTATINS; DOWN-REGULATION; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; UP-REGULATION;

EID: 37249014466     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.08.015     Document Type: Article

References (47)

1. Dobrin P.B., Baker W.H., and Gley W.C. Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. Arch Surg 119 (1984) 405-409
2. Baxter B.T., McGee G.S., Shively V.P., Drummond I.A., Dixit S.N., Yamauchi M., et al. Elastin content, cross-links, and mRNA in normal and aneurysmal human aorta. J Vasc Surg 16 (1992) 192-200
3. Dobrin P.B., and Mrkvicka R. Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg 2 (1994) 484-488
4. Campa J.S., Greenhalgh R.M., and Powell J.T. Elastin degradation in abdominal aortic aneurysms. Atherosclerosis 65 (1987) 13-21
5. Hobeika M.J., Thompson R.W., Muhs B.E., Brooks P.C., and Gagne P.J. MMPs in peripheral vascular disease. J Vasc Surg 45 (2007) 849-857
6. Knox J.B., Sukhova G.K., Whittemore A.D., and Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95 (1997) 205-212
7. Thompson R.W., and Parks W.C. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci 800 (1996) 157-174
8. Carrell T.W., Burnand K.G., Wells G.M., Clements J.M., and Smith A. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 105 (2002) 477-482
9. Roberts R. Lysosomal cysteine proteases: structure, function and inhibition of cathepsins. Drug News Perspect 18 (2005) 605-614
10. Chapman H.A., Riese R.J., and Shi G.P. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol 59 (1997) 63-88
11. Lecaille F., Kaleta J., and Bromme D. Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem Rev 102 (2002) 4459-4488
12. Kirschke H., Langner J., Wiederanders B., Ansorge S., and Bohley P. Intracellular protein degradation. IV. Isolation and characterization of peptidases from rat liver lysosomes. Acta Biol Med Ger 28 (1972) 305-322
13. Abrahamson M., Alvarez-Fernandez M., and Nathanson C.M. Cystatins. Biochem Soc Symp (2003) 179-199
14. Yasuda Y., Li Z., Greenbaum D., Bogyo M., Weber E., and Bromme D. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages. J Biol Chem 279 (2004) 36761-36770
15. Garnero P., Borel O., Byrjalsen I., Ferreras M., Drake F.H., McQueney M.S., et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273 (1998) 32347-32352
16. Kostoulas G., Lang A., Nagase H., and Baici A. Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinases. FEBS Lett 455 (1999) 286-290
17. Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85 (2005) 1-31
18. Lindholt J.S., and Shi G.P. Chronic inflammation, immune response, and infection in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 31 (2006) 453-463
19. Gacko M., and Chyczewski L. Activity and localization of cathepsin B, D and G in aortic aneurysm. Int Surg 82 (1997) 398-402
20. Gacko M., and Glowinski S. Cathepsin D and cathepsin L activities in aortic aneurysm wall and parietal thrombus. Clin Chem Lab Med 36 (1998) 449-452
21. Lindholt J.S., Erlandsen E.J., and Henneberg E.W. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. Br J Surg 88 (2001) 1472-1475
22. Liu J., Sukhova G.K., Yang J.T., Sun J., Ma L., Ren A., et al. Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis (2005)
23. Shi G.P., Sukhova G.K., Grubb A., Ducharme A., Rhode L.H., Lee R.T., et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 104 (1999) 1191-1197
24. Gacko M., Ostapowicz R., Chrostek L., Worowska A., and Kordecki K. Activity of enzymes with different subcellular localization in the blood plasma of patients with aortic aneurysm. Med Sci Monit 11 (2005) CR211-CR213
25. Pyo R., Lee J.K., Shipley J.M., Curci J.A., Mao D., Ziporin S.J., et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 105 (2000) 1641-1649
26. Thompson R.W., Holmes D.R., Mertens R.A., Liao S., Botney M.D., Mecham R.P., et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 96 (1995) 318-326
27. McMillan W.D., Patterson B.K., Keen R.R., Shively V.P., Cipollone M., and Pearce W.H. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arterioscler Thromb Vasc Biol 15 (1995) 1139-1144
28. Schwartz W.N., and Barrett A.J. Human cathepsin H. Biochem J 191 (1980) 487-497
29. Tung W.S., Lee J.K., and Thompson R.W. Simultaneous analysis of 1176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array. J Vasc Surg 34 (2001) 143-150
30. van Vlijmen-van Keulen C.J., Vahl A.C., Hennekam R.C., Rauwerda J.A., and Pals G. Genetic linkage of candidate genes in families with abdominal aortic aneurysms?. Eur J Vasc Endovasc Surg 26 (2003) 205-210
31. Gacko M., Chyczewski L., and Chrostek L. Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm. Pol J Pathol 50 (1999) 83-86
32. Sukhova G.K., Shi G.P., Simon D.I., Chapman H.A., and Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 102 (1998) 576-583
33. Abdul-Hussien H., Soekhoe R.G., Weber E., der Thusen J.H., Kleemann R., Mulder A., et al. Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am J Pathol 170 (2007) 809-817
34. Vorp D.A., Lee P.C., Wang D.H., Makaroun M.S., Nemoto E.M., Ogawa S., and Webster M.W. Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J Vasc Surg 34 (2001) 291-299
35. Sukhova G.K., Wang B., Libby P., Pan J.H., Zhang Y., Grubb A., et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res 96 (2005) 368-375
36. Eriksson P., Jones K.G., Brown L.C., Greenhalgh R.M., Hamsten A., and Powell J.T. Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms. Br J Surg 91 (2004) 86-89
37. Ray S., Lukyanov P., and Ochieng J. Members of the cystatin superfamily interact with MMP-9 and protect it from autolytic degradation without affecting its gelatinolytic activities. Biochim. Biophys Acta 1652 (2003) 91-102
38. Tsubokawa T., Solaroglu I., Yatsushige Y., Cahill J., Yata K., and Zhang J.H. Cathepsin and calpain inhibitor E64d attenuates MMP-9 activity after focal cerebral ischemia in rats. Stroke 37 (2006) 1888-1894
39. Kitamoto S., Galina K., Sukhova G.K., Sun J., Yang M., Libby P., et al. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. Circulation 115 (2007) 2065-2075
40. Yanamandra N., Gumidyala K.V., Waldron K.G., Gujrati M., Olivero W.C., Dinh D.H., et al. Blockade of cathepsin B expression in human glioblastoma cells is associated with suppression of angiogenesis. Oncogene 23 (2004) 2224-2230
41. Tsubokawa T., Solaroglu I., Yatsushige H., Cahill J., Yata K., and Zhang J.H. Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats. Stroke 37 (2006) 1888-1894
42. Im E., Venkatakrishnan A., and Kazlauskas A. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells. Mol Biol Cell 16 (2005) 3488-3500
43. Guinec N., Dalet-Fumeron V., and Pagano M. "In vitro" study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like and L. Digestion of collagen IV, laminin, fibronectin, and release of gelatinase activities from basement membrane fibronectin. Biol Chem Hoppe Seyler 374 (1993) 1135-1146
44. Taleb S., Cancello R., Clement K., and Lacasa D. Cathepsins promote human pre-adipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology 147 (2006) 4950-4959
45. Sukhova G.K., and Shi G.P. Do cathepsins play a role in abdominal aortic aneurysm pathogenesis?. Ann N Y Acad Sci 1085 (2006) 161-169
46. Newby A.C., and Johnson J.L. Genetic strategies to elucidate the roles of matrix metalloproteinases in atherosclerotic plaque growth and stability. Circ Res 97 (2005) 958-960
47. Gough P.J., Gomez I.G., Wille P.T., and Raines E.W. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 116 (2006) 59-69